Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android. Learn more here!

A rare syndrome characterized by multiple hamartomas (small flesh-colored nodules on the skin made up by hair follicles and small wart-like growths) and a risk of breast, thyroid, and uterine neoplasias.

Multiple Hamartoma Syndrome.

Named after Rachel Cowden, the first patient described.

More than 200 cases have been described in the medical literature. Males and females are equally affected, however, thyroid cancer is the most common cancer in males, whereas breast cancer is the most common in affected women.

Autosomal dominant with interfamilial and intrafamilial variance.

Cowden syndrome results from a mutation in the PTEN (phosphatase and tensin homologue) tumor suppressor gene. (Synonym: MMAC1 [mutated in multiple advanced cancers-1] gene), which has been mapped to 10q23. PTEN encodes a phosphatase involved in regulation of growth, survival, and death of cells. The lack of PTEN functionality appears to be responsible for the uncontrolled proliferation of certain cells and the formation of hamartomas (and neoplasias).

Based on the clinical findings. Usually Cowden syndrome is diagnosed only after the first year of life. Mucocutaneous signs are most pathognomonic but least obvious. Signs include acral keratosis, facial trichilemmomas, oral papillomas, and scrotal tongue. The International Cowden Syndrome Consortium summarized the diagnostic features into major criteria (macrocephaly, thyroid cancer, breast cancer, and Lhermitte-Duclos disease [see Other Conditions to Be Considered]) and minor criteria (mental retardation, nonmalignant thyroid changes, nonmalignant breast tumors, gastrointestinal hamartomas, lipomas, fibromas, urogenital tumors). Mucocutaneous lesions alone can meet the criteria under certain circumstances (depending on the number and type of lesions). The diagnosis is considered very likely when one major and three minor criteria, two major criteria (but only if either macrocephaly or Lhermitte-Duclos disease is present), or four minor criteria are met.

Macrocephaly, not secondary to hydrocephalus, may be present in up to 39% of patients and usually becomes evident only after the first year of life. It is often accompanied by frontal bossing, adenoid facies, hypoplastic maxilla and mandible, and high arched palate. Mild mental retardation with seizures and cerebellar signs (tremor) is present in 12% of patients. Kyphosis, kyphoscoliosis, and anomalies of the thyroid gland are reported in approximately two thirds of patients and may include multinodular goiter, adenomas, and follicular adenocarcinoma. Patients should undergo regular checkups for signs of thyroid cancer (especially men). The most serious malignancy in females is (early-onset) breast cancer, which may affect up to one third of female patients and often occurs bilaterally. Gastrointestinal adenomas, hamartomatous and hyperplastic polyps, lymphangiomas, and ganglioneurofibromas may occur in almost three fourths of patients and can be localized anywhere between the esophagus and the anus (including gallbladder) but are most common in the colon. Malignant transformation is a possible risk. Urogenital lesions include carcinomas of the kidneys, urethra, and uterine cervix, ovarian cysts, leiomyomas, and teratomas, vaginal and vulvar cysts, and testicular ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.